lenalidomide-dexamethasone:

Iván Maray1, Cristina Álvarez-Asteinza1, Clara Luz Fernández-Laguna1

  • 1Department of Pharmacy, Hospital Universitario Central de Asturias, Oviedo, Spain.

概括

在多发性骨髓瘤中预测莱纳利多米德剂量调整至关重要. 老年患者和中性粒细胞计数较低的患者更有可能需要因不良事件而减少剂量.